-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In the adaptive immune system, the diversity of antibody molecules produced by B lymphocytes is the key effector molecule in mediating humoral immunity.
Clinically, mutations in AID protein have been found to be closely related to immunodeficiency disease type 2 hyper-IgM syndrome, and these mutations are mostly recessive inheritance
On April 26, 2022, researcher Hu Jiazhi's research group from the School of Life Sciences of Peking University and Peking University-Tsinghua Life Science Joint Center cooperated with researcher Meng Feilong's research group of the Center for Excellence in Molecular and Cell Science (Institute of Biochemistry and Cell Biology), Chinese Academy of Sciences.
Figure 1.
By means of endogenous protein tagging and CRISPR-Sirius targeting, the researchers found that AID DCs existed in the form of aggregates in B lymphocytes, and the aggregates were sequestered outside the IgH region and lost the targeting antibody gene.
Figure 2.
Through intracellular co-expression experiments, the researchers found that AID DC aggregates could specifically capture free wild-type AID in the nucleus into the aggregates (Fig.
Figure 3.
Hu Jiazhi and Meng Feilong are the co-corresponding authors of the article
